Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Charter Communications
CHTR
5
MasterCard
MA
US Stock MarketDetailed Quotes
PRQR ProQR Therapeutics
- 1.560
- -0.240-13.33%
Close May 6 16:00 ET
- 1.560
- 0.0000.00%
Post 20:01 ET
164.13MMarket Cap-4.29P/E (TTM)
1.800High1.500Low1.03MVolume1.750Open1.800Pre Close1.63MTurnover1.60%Turnover RatioLossP/E (Static)105.21MShares4.62052wk High1.63P/B100.52MFloat Cap1.07052wk Low--Dividend TTM64.44MShs Float27.600Historical High--Div YieldTTM16.67%Amplitude0.530Historical Low1.577Avg Price1Lot Size
ProQR Therapeutics Key Stats
EPS
According to the latest financial report of ProQR Therapeutics, the latest earnings per share (TTM) for the company is -0.09. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: EUR
Quarterly
Loading...
FCF
Interested in knowing about ProQR Therapeutics's free cash flow? The latest report shows it as -9.48M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: EUR
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of ProQR Therapeutics shows that the company's current ratio is 3.95, indicating healthy liquidity.
Currency: EUR
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of ProQR Therapeutics, the quick ratio is 3.89, indicating that the company can meet its short-term debt obligations.
Currency: EUR
Quarterly
Loading...
ROE
Want to learn more about the financial health of ProQR Therapeutics? The latest ROE figure is -16.39%, indicating that the company has stable profitability.
Currency: EUR
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of ProQR Therapeutics, the total asset return on investment (ROA) is -6.77%.
Currency: EUR
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check ProQR Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: EUR
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of ProQR Therapeutics, the net profit margin is -216.04%, which is a good sign for its profitability.
Currency: EUR
Quarterly
Loading...
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
